127 filings
Page 3 of 7
6-K
049r5xcy8x0z1 9awr
17 May 22
Current report (foreign)
8:26am
6-K
fanw7ofg tn
17 May 22
Mereo BioPharma Announces Appointment of Dr. Abdul Mullick to Board of Directors
8:19am
6-K
nw3ybkjta8l
9 May 22
Current report (foreign)
8:15am
6-K
ndn6 643vf0qwio9lp
9 May 22
Current report (foreign)
8:06am
6-K
2ddp9ox
31 Mar 22
Mereo BioPharma Reports Full Year 2021 Financial Results and Recent Highlights
4:18pm
6-K
yx5xs9 bjqw
14 Mar 22
Current report (foreign)
10:05am
6-K
fasj6szfqx3x42w7
1 Mar 22
Mereo BioPharma Announces Appointment of Anne Hyland to Board of Directors
9:55am
6-K
6ex0t8yd
22 Dec 21
Alvelestat reported safe and well-tolerated in patients with COVID-19
7:45am
6-K
lfdx5sa
30 Nov 21
Mereo BioPharma Reports Interim Data from ACTIVATE Phase 1b/2 Open Label Study of
7:51am
6-K
z9nxrb p49p0
4 Nov 21
Current report (foreign)
4:17pm
6-K
ojkhkf8j e4q
2 Nov 21
Current report (foreign)
4:16pm
6-K
4ecgk daz2xe
26 Oct 21
Current report (foreign)
4:16pm
6-K
r2rl2afsb r4nkc
26 Oct 21
Mereo BioPharma Receives U.S. Orphan Drug Designation for alvelestat in About Mereo BioPharma
10:07am
6-K
unv6a5t
1 Oct 21
Current report (foreign)
4:43pm
6-K
m1itqdp5
20 Sep 21
Mereo BioPharma Announces Appointment of Pierre Jacquet, M.D., Ph.D. to Board of Directors
8:20am
6-K
y87uulg
20 Jul 21
Current report (foreign)
4:16pm
6-K
fmym7a9x
2 Jun 21
Current report (foreign)
8:24am
6-K
bvjjiydytng4g8wpi
28 May 21
Current report (foreign)
4:07pm
6-K
t783hjrzocc8l1ju
30 Apr 21
Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian Cancer
4:05pm
6-K
njjo17mt0zeaa
16 Apr 21
Current report (foreign)
4:10pm